Ft. Lauderdale Conference

May 19 - May 20, 2017

Welcome/Introduction• Conference Chairs: Maria Abreu, MD and Eugene Schiff, MD

Diagnosis and management of primary biliary cholangitis (PBC)• Cynthia Levy, MD

Advances in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)• Naim Alkhouri, MD

Management of drug-induced liver injury (DILI)• Paul Martin, MD

Advances in opioid-induced constipation management• Baha Moshiree, MD, MS

Fecal incontinence: Sealing the leak• Satish Rao, MD, PhD

Diarrhea: Managing exocrine pancreatic insufficiency (EPI), irritable bowel syndrome (IBS)
and small bowel bacterial overgrowth (SIBO)• Lawrence Schiller, MD

Emerging hepatitis C (HCV) therapies-2017/2018• Robert Brown, MD, MPH

Does curing HCV lead to HBV reactivation and higher risk of hepatocellular carcinoma (HCC)?• Fred Poordad, MD

Complications of cirrhosis: hepatic encephalopathy, ascites and variceal bleeding• Kimberly Brown, MD

HCC: Update on role of metabolic syndrome, screening and treatment• Hashem El-Serag, MD, MPH

Reflux Hypersensitivity: A newly diagnosed esophageal disorder• Ronnie Fass, MD

Impact of weight loss surgery on esophageal function• Michael Vaezi, MD, PhD, MSc

Barrett's esophagus and esophageal cancer-Why can't we have more of an impact?• Joel Richter, MD

Positioning new therapies for ulcerative colitis and Crohn's disease• Stephen Hanauer, MD

The evolving role of therapeutic drug monitoring in inflammatory bowel disease (IBD)• Maria Abreu, MD

Management of celiac disease• Joseph Murray, MD

Dallas Conference

Mar 24 - Mar 25, 2017

Cleveland Conference

Jun 3 - Jun 4, 2016

Dallas Conference

Apr 8 - Apr 9, 2016

Chicago Conference

Sep 25 - Sep 26, 2015

Ft. Lauderdale Conference

May 29 - May 30, 2015

Dallas Conference

Apr 10 - Apr 11, 2015